Iron(ii) spin crossover (SCO) materials have been widely studied as molecular switches with a wide variety of potential applications, including as displays, sensors, actuators or memory components. Most SCO materials have been either monometallic or polymeric, and it is only relatively recently that chemists have really started to focus on linking multiple metal centres together within the one, discrete, molecule in an effort to enhance the SCO properties, such as abrupt, hysteretic, and multistep switching, as well as the potential for quantum cellular automata, whilst still being readily amenable to characterisation. Here we present a review of the ligand designs of the last two decades that have led to self assembly of discrete di- to poly-nuclear iron(ii) complexes of helicate, cage, cube, and other supramolecular architectures with rich SCO activity, and to an increased focus on host-guest interactions. Analysis of selected octahedral distortion parameters (Σ, CShM) reveals interesting differences between these structural types, for example that the iron(ii) centres in grids are generally significantly more distorted than those in squares or cages, yet are still SCO-active. Of the 127 complexes reviewed (79 published 2012-Feb. 2018), 54% are dinuclear, 10% trinuclear, 31% tetranuclear, and the remaining 5% are penta, hexa and octanuclear. Of the 93 designer ligands utilised in these polynuclear architectures: 60 feature azoles; 55 provide all donors to the Fe(ii) centres (no co-ligands coordinated) and form exclusively 5-membered chelate rings via either bidentate azole-imine/pyridine or tridentate heterocycle-imine/amine/thioether/pyridine-heterocycle binding pockets.
A family of five new bis-bidentate azole-triazole Rat ligands (1,3-bis(5-azole)-4-isobutyl-4H-1,2,4-triazol-3-yl)benzene), varying in choice of azole (2-imidazole, 4-imidazole, 1-methyl-4-imidazole, 4-oxazole and 4-thiazole), and the corresponding family of spin-crossover (SCO) and redox...
The first examples of azole-triazole Rat ligands, bidentate L 4NMeIm (3-(1-methyl-1H-imidazol-4-yl)-5-phenyl-4-(p-tolyl)-4H-1,2,4-triazole) and L 4SIm (4-(5-phenyl-4-(ptolyl)-4H-1,2,4-triazol-3-yl)thiazole), have been prepared, by extension of the general synthesis used to access many examples of azine-triazoles. The tris-L Fe II complexes of the azine-triazoles are consistently low spin (LS). As intended, these new azole-triazole ligands provide lower field strengths, resulting in high-spin (HS) [Fe II (L 4NMeIm ) 3 ](BF 4 ) 2 (1•4H 2 O) and spin crossover (SCO) active [Fe II ( L 4SIm ) 3 ](BF 4 ) 2 (2•0.5H 2 O). Single-crystal structure determinations revealed that at 100 K 1• solvents is HS whereas 2•solvents is LS. Solid-state variable temperature magnetic studies of air-dried crystals showed that the methylimidazole-triazole complex 1•4H 2 O remains HS while the thiazole-triazole complex 2•0.5H 2 O undergoes a two-step gradual SCO (T 1/2 approximately 275 and 350 K). Variable-temperature Evans method NMR studies of 2, in five different solvents (CD 3 NO 2 , CD 3 CN, CD 3 COCD 3 , CD 2 Cl 2 , and CDCl 3 ) gave T 1/2 values in a relatively narrow range, 214−259 K. These T 1/2 values did not correlate with the solvent polarity index P′ (R 2 = 0.25) but did correlate with the solvent basicity parameter SB (R 2 = 0.90). Variable-temperature UV−vis studies on a golden yellow CH 3 CN solution of 2, with monitoring of the d−d transition at 530 nm (ε = 39 L mol −1 cm −1 at 293 K) while the solution was heated from 253 to 303 K, showed that the high-spin fraction increased from 0.51 to 0.77. Cyclic voltammetry studies in CH 3 CN revealed a Fe(III)/Fe(II) redox process that was reversible for 1 and irreversible for 2, with significant tuning of the E pa value: the methylimidazole-triazole complex 1 is significantly easier to oxidize (0.46 V) than the thiazole-triazole complex 2 (0.68 V; both vs 0.01 M Ag/AgNO 3 ).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.